Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.

× No keyword cloud information.

11 in total

1. THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS.

Authors: M C HOLMES; F M BURNET
Journal: Ann Intern Med Date: 1963-09 Impact factor: 25.391

2. Studies on the character and staining of fibrin.

Authors: A C LENDRUM; D S FRASER; W SLIDDERS; R HENDERSON
Journal: J Clin Pathol Date: 1962-09 Impact factor: 3.411

3. Spontaneous auto-immune disease in NZB/BL mice.

Authors: B J HELYER; J B HOWIE
Journal: Br J Haematol Date: 1963-04 Impact factor: 6.998

Review 4. Symposium on immunosuppressive drugs. Variable influences of antitumor drugs and progestational agents on immune responses in rodents.

Authors: R F Haines; A G Johnson; H G Petering
Journal: Fed Proc Date: 1967 May-Jun

Review 5. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

Authors: G B Elion
Journal: Fed Proc Date: 1967 May-Jun

Review 6. Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs.

Authors: D A Karnofsky
Journal: Fed Proc Date: 1967 May-Jun

7. Immunopathology of New Zealand black (NZB) mice.

Authors: J East; M A de Sousa; D M Parrott
Journal: Transplantation Date: 1965-11 Impact factor: 4.939

8. Pathological changes of thymic epithelial cells and autoimmune disease in NZB, NZW and (NZB x NZW)F1 mice.

Authors: M J de Vries; W Hijmans
Journal: Immunology Date: 1967-02 Impact factor: 7.397

9. Immune reactivity prior to development of thymic lymphoma in C57BL mice.

Authors: R G Doell; C De Vaux St Cyr; P Grabar
Journal: Int J Cancer Date: 1967-03-15 Impact factor: 7.396

10. Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma.

Authors: R C Mellors
Journal: Blood Date: 1966-04 Impact factor: 22.113

23 in total

1. Immunosuppression and malignancy.

Authors:
Journal: Br Med J Date: 1972-09-23

2. Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice.

Authors: J F Bach; M Dardenne; J C Salomon
Journal: Clin Exp Immunol Date: 1973-06 Impact factor: 4.330

3. Tumour development following immunosuppression.

Authors: A C Allison
Journal: Proc R Soc Med Date: 1970-10

4. The disease of the NZB mouse. I. Examination of ovum fusion derived tetraparental NZB:CFW chimaeras.

Authors: R D Barnes; M Tuffrey; J Kingman; C Thornton; M W Turner
Journal: Clin Exp Immunol Date: 1972-08 Impact factor: 4.330

Review 5. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors: T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal: Transplant Rev Date: 1971

6. Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice.

Authors: E Lemmel; E R Hurd; M Ziff
Journal: Clin Exp Immunol Date: 1971-02 Impact factor: 4.330

Review 7. The treatment of lupus nephritis.

Authors: J S Cameron
Journal: Pediatr Nephrol Date: 1989-07 Impact factor: 3.714

Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.